WeedLife News Network
DEA Blocks Medical Cannabis: Patients Suffer
WASHINGTON, D.C / ACCESS Newswire / June 29, 2025 / The U.S. Drug Enforcement Administration (DEA) is reeling from a constitutional crisis as its controversial Administrative Law Judge (ALJ) system crumbles under Supreme Court rulings, while MMJ BioPharma Cultivation intensifies its legal battle against the agency's alleged sabotage of medical cannabis research. The fallout has triggered retirements and disciplinary actions within the DEA's Diversion Control Division, with insiders dubbing the removed officials "DOGE Casualties" a nod to their NON alignment with Trump-era policies that prioritized science over obstruction.
The DEA's "Last Stand": An Unconstitutional Tribunal Defies the Supreme Court
For over 2,387 days, MMJ BioPharma Cultivation, a company developing FDA sanctioned cannabis therapies for Huntington's Disease and Multiple Sclerosis, has been trapped in the DEA's Administrative Law hearing process. The exact system the Supreme Court declared unconstitutional in Axon Enterprise v. FTC (2023) and Jarkesy v. SEC (2024). These rulings found such agency tribunals violate:
Copyright
©420 Intel
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
